Hospital groups, GPO push back on CMS’ 2027 outpatient rule
Ella Jeffries / beckershospitalreview - Four groups are condemning CMS’ proposed 2027 Hospital Outpatient Prospective Payment System and Ambulatory Surgery Center rule, which would cut what Medicare pays hospitals for 340B drugs and expand site-neutral payments into a new category of services. …
AI Summary: Major hospital groups and purchasing GPOs are pushing back on CMS’ proposed 2027 outpatient payment rule, warning that reimbursement changes could disrupt provider margins, patient access and group purchasing dynamics. CMS’ proposal would alter outpatient payment calculations; hospitals argue the revisions threaten financial viability of some outpatient services and request policy rework and deeper stakeholder engagement.
Ovarian Function Suppression Plus Tamoxifen Significantly Reduces Premenopausal Breast Cancer Recurrence Over Tamoxifen and Further Reduction Is Seen When Combined with Exemestane
esmo - Findings from the SOFT and TEXT studies
AI Summary: A new analysis shows adding ovarian function suppression to tamoxifen substantially lowers recurrence in premenopausal breast cancer patients compared with tamoxifen alone, with even greater reduction when switched to exemestane. Clinicians should note the clear endocrine benefit — and patients can sigh with cautious optimism while weighing menopausal side effects.